(NASDAQ: DMTK) Dermtech's forecast annual revenue growth rate of 26.4% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.11%.
Dermtech's revenue in 2024 is $15,664,000.On average, 1 Wall Street analysts forecast DMTK's revenue for 2024 to be $692,267,281, with the lowest DMTK revenue forecast at $692,267,281, and the highest DMTK revenue forecast at $692,267,281.
In 2025, DMTK is forecast to generate $846,104,455 in revenue, with the lowest revenue forecast at $846,104,455 and the highest revenue forecast at $846,104,455.